Full safety profile Multiple species 96-well Service outputs aProximate TM Evaluation of KIM-1, NGAL, and clusterin, three FDA-approved biomarkers of kidney toxicity Cell viability: ATP, LDH, and TEER measurements Assays Kidney toxicity assays Assessment of renal drug safety Models aProximate TM kidney proximal tubule cells (from human, mouse, rat, and dog) Timeline 2-3 months How can Newcells kidney tissue models be used to assess renal toxicity
How GLP-1s Can Help Over a year after completing treatment, Id stand in my closet, furious at clothes that no longer fit and terrified of cancers continued hold on my body
Clinical signs of cobalamin deficiency in dogs are often vague and difficult to attribute to anything specific
Yes in consultation with your physician
Research supports continued GLP-1 use as a maintenance strategy if discontinuation triggers significant regain